Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Department of Ophthalmology, Kanazawa Medical University, Kanazawa 9200265, Japan.
Cells. 2022 Apr 8;11(8):1266. doi: 10.3390/cells11081266.
Changes in intracellular reactive oxygen species (ROS) levels due to remodeling of antioxidant defense can affect the status of biological homeostasis in aging/oxidative stress. Peroxiredoxin 6 (Prdx6), an antioxidant gene downstream target for the Nrf2 pathway, plays a role in regulating ROS homeostasis. Using aging human (h) lens epithelial cells (LECs) or -deficient ( mouse (m) LECs, here we showed that dichlorofluorescein (DCF) oxidation or HO were strictly controlled by Prdx6. We observed that a moderate degree of oxidative stress augmented Nrf2-mediated Prdx6 expression, while higher doses of HO (≥100 µM) caused a dramatic loss of Prdx6 expression, resulting in increased DCF oxidation and HO amplification and cell death. Mechanistically, at increased oxidative stress, Nrf2 upregulated transcriptional factor Klf9, and that Klf9 bound to the promoter and repressed the Prdx6 gene. Similarly, cells overexpressing Klf9 displayed Klf9-dependent Prdx6 suppression and DCF oxidation with HO amplification, while Klf9 reversed the process. Our data revealed that HO and DCF oxidation levels play a hormetical role, and the Nrf2-Klf9-Prdx6 pathway is pivotal for the phenomena under the conditions of oxidative load/aging. On the whole, the results demonstrate that oxidative hormetical response is essentially based on levels of oxidative triggering and the status of Klf9-Prdx6 pathway activation; thus, Klf9 can be considered as a therapeutic target for hormetic shifting of cellular defense to improve protective resilience to oxidative stress.
细胞内活性氧(ROS)水平的变化由于抗氧化防御的重塑会影响衰老/氧化应激中生物内稳态的状态。过氧化物酶 6(Prdx6)是 Nrf2 途径的抗氧化基因下游靶标,在调节 ROS 内稳态中发挥作用。使用衰老的人(h)晶状体上皮细胞(LEC)或 -缺陷(鼠(m)LEC,我们在这里表明,二氯荧光素(DCF)氧化或 HO 受到 Prdx6 的严格控制。我们观察到,适度的氧化应激增强了 Nrf2 介导的 Prdx6 表达,而更高剂量的 HO(≥100µM)导致 Prdx6 表达急剧丧失,导致 DCF 氧化和 HO 放大以及细胞死亡增加。从机制上讲,在氧化应激增加时,Nrf2 上调转录因子 Klf9,而 Klf9 结合到启动子并抑制 Prdx6 基因。同样,过表达 Klf9 的细胞显示 Klf9 依赖性 Prdx6 抑制和 DCF 氧化与 HO 放大,而 Klf9 逆转了这一过程。我们的数据表明,HO 和 DCF 氧化水平起着激素作用,并且 Nrf2-Klf9-Prdx6 途径对于氧化负荷/衰老条件下的现象至关重要。总的来说,这些结果表明,氧化激素反应本质上基于氧化触发的水平和 Klf9-Prdx6 途径激活的状态;因此,Klf9 可以被认为是一种治疗靶点,用于将细胞防御的激素转移以提高对氧化应激的保护弹性。